Tianshu Yu
Hangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Abnormal expansion of peripheral helper T cells in primary immune thrombocytopenia.
Journal: Platelets
Published: March 31, 2026
Advances in strategies to improve the immunotherapeutic efficacy of chimeric antigen receptor-T cell therapy for lymphoma.
Journal: Cancer biology & medicine
Published: April 15, 2025
Inhibiting mTORC1 pathway by rapamycin restores the balance of CD8+ T cell subsets and reduces CD8+ T cell-mediated platelet destruction in immune thrombocytopenia.
Journal: Thrombosis research
Published: March 10, 2025
The mTORC1 pathway participate in hyper-function of B cells in immune thrombocytopenia.
Journal: Annals of hematology
Published: January 31, 2023
Clonal hematopoiesis in primary immune thrombocytopenia.
Journal: Blood cancer journal
Published: January 21, 2022
Single-dose versus low-dose rituximab in corticosteroid-resistant or relapsed ITP: A multicenter, randomized, controlled study.
Journal: American journal of hematology
Published: August 28, 2021
Atorvastatin restores imbalance of cluster of differentiation 4 (CD4)+ T cells in immune thrombocytopenia in vivo and in vitro.
Journal: British journal of haematology
Published: July 15, 2021
Low-Dose Decitabine Inhibits Cytotoxic T Lymphocytes-Mediated Platelet Destruction via Modulating PD-1 Methylation in Immune Thrombocytopenia.
Journal: Frontiers in immunology
Published: November 18, 2020
Indirubin modulates CD4+ T-cell homeostasis via PD1/PTEN/AKT signalling pathway in immune thrombocytopenia.
Journal: Journal of cellular and molecular medicine
Published: August 08, 2018
Last Updated: 09/26/2026